The platform's published patient materials note that studies have generally shown injectable formulations to produce stronger weight loss outcomes, though individual results depend on numerous clinical factors
Not valid with other offers or promotions
Chan School of Public Health analysed 3,572 pregnancies in women who were taking GLP-1 drugs prior to conception, including 1,467 in women with type 2 diabetes
Poor sleep disrupts GLP-1 (satiety hormone) production
Given that orally formulated GLP-1 agonists have lower efficacy than injectables, small molecule GLP-1 mimics are expected to make more headway
Neuroprotective effects: Clinical research has aimed to evaluate the effect of liraglutide on cerebral glucose uptake, cognitive measures, cortical volume, and safety in individuals with mild to moderate Alzheimer's disease